Deprexil

Deprexil is a multi-ingredient dietary supplement developed by Catalysis S.L. for the management of mild to moderate depression and mood disorders. The product is manufactured using a proprietary molecular activation process designed to enhance the antioxidant and biological properties of its components. Its mechanism of action involves the regulation of neuronal metabolism and the stabilization of calcium homeostasis, which helps mitigate the neuroendocrine imbalances associated with depressive states. Clinical studies have evaluated its efficacy in primary depression, secondary depression related to concomitant pathologies, and post-COVID-19 syndrome, focusing on its ability to modulate levels of neurotransmitters such as serotonin, dopamine, and GABA, as well as stress hormones like cortisol.

Brand names

Deprexil

Other names

Deprexil capsules